Sunday, June 16, 2024

Hull occupational health firm makes duo of acquisitions

Hull-based Latus Health, a provider of employee health and wellbeing solutions, has acquired ELAS Occupational Health (ELAS) and The Industrial Diagnostics Company (IDC) from Citation Group.

Over the last five years, Latus has delivered significant organic growth and, coupled with these strategic acquisitions, the group will be able to offer a broader range of services to more customers.

ELAS’ expertise in health surveillance directly complements Latus’ solutions to ensure its current and future customer base has access to a holistic solution for all their occupational health needs, including a unique approach in providing mobile health surveillance and on-site industrial diagnostics, such as chest x-rays, as well as audiology services, across the UK.

As part of the transaction, Latus has appointed Graham Ewart as chairman. Ewart brings extensive experience from the healthcare sector from his role as CEO of previous NorthEdge backed business Direct Healthcare Group, which was sold to ArchiMed in 2019.

Jack Latus, CEO of Latus Health, said: “We have always been committed to delivering the highest quality of care and service for our clients, whilst improving the way occupational health is delivered through the implementation of innovative digital solutions.

“The acquisition of ELAS and IDC are a testament to that commitment, and we are excited to welcome their team of dedicated professionals to join the Latus mission. Together, we will continue to innovate and drive forward the occupational health industry under the knowledge that happier and healthier teams deliver better results.”

Vikki Blease, head of occupational health at ELAS, said: “We are very excited to be part of Latus who have an exciting vision for occupational health. The Latus team are dynamic and share our passion and drive for best-in-class occupational health.

“For clients of both Latus and ELAS, this acquisition promises a seamless transition with no disruption to existing services. Clients will continue to receive the same high-quality care and attention they have come to expect, with the added benefit of access to an even wider range of services.”

Richard Williams, partner at TDC, whose Impact Fund backed the acquisitions, said: “TDC are pleased to have supported Latus in its recent acquisition of ELAS and IDC, marking our second investment from our Impact Fund. The Fund targets SMEs across the North that were disrupted by Covid-19 and the macro-economic conditions experienced following this period, to support their recovery and with a specific focus on growing employment in the local region.

“As well strengthening the position of Latus within the market, the transaction will also help in the acquisition of a number of key senior hires that will strengthen the existing board and help generate future growth. We look forward to supporting management as they drive the business into its next stage of growth.”

Graham Ewart, chairman at Latus Health, said: “Latus Health continues on a very steep growth trajectory backed by our vision to truly innovate in the occupational health space.

“Through both our own in-house developed technologies, and the unique offerings we have acquired, Latus are providing our ever-expanding customer base with a fully integrated and holistic package of solutions to drive value-adding productivity within the workplace.”

Latus Health was advised on its acquisition of ELAS and IDC from Citation by the Clearwater International Leeds office, led by partner Richard Goldsack, associate director John Haygarth, and director Glenn Clarke.

Legal advice was provided by the Shoosmiths Leeds office, led by partners James Foster and Simon Procter, and financial and tax advice by Martin Athey, Charles Evers, Fletcher Adamowicz and Emily Caine of Translink CF, the specialist CF division of BHP.

TDC legal advice was provided by the Pinsent Masons Manchester Office, led by partner Tim Fearn and Catherine Donnelly.

A message from the Editor:

Thank you for reading this story on our news site - please take a moment to read this important message:

As you know, our aim is to bring you, the reader, an editorially led news site and magazine but journalism costs money and we rely on advertising, print and digital revenues to help to support them.

With the Covid-19 pandemichaving a major impact on our industry as a whole, the advertising revenues we normally receive, which helps us cover the cost of our journalists and this website, have been drastically affected.

As such we need your help. If you can support our news sites/magazines with either a small donation of even £1, or a subscription to our magazine, which costs just £31.50 per year, (inc p&P and mailed direct to your door) your generosity will help us weather the storm and continue in our quest to deliver quality journalism.

As a subscriber, you will have unlimited access to our web site and magazine. You'll also be offered VIP invitations to our events, preferential rates to all our awards and get access to exclusive newsletters and content.

Just click here to subscribe and in the meantime may I wish you the very best.

Latest news

Related news